Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Autoimmune Disease Therapeutics Market, by Indication
1.4.2 Asia Pacific Autoimmune Disease Therapeutics Market, by Drug Class
1.4.3 Asia Pacific Autoimmune Disease Therapeutics Market, by Distribution Channel
1.4.4 Asia Pacific Autoimmune Disease Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Autoimmune Disease Therapeutics Market by Indication
3.1 Asia Pacific Rheumatic Disease Market by Country
3.2 Asia Pacific Diabetes Market by Country
3.3 Asia Pacific Multiple Sclerosis Market by Country
3.4 Asia Pacific Inflammatory Bowel Disease Market by Country
3.5 Asia Pacific Other Indications Market by Country
Chapter 4. Asia Pacific Autoimmune Disease Therapeutics Market by Drug Class
4.1 Asia Pacific Anti-Inflammatory Market by Country
4.2 Asia Pacific Anti-Hyperglycemics Market by Country
4.3 Asia Pacific NSAIDs Market by Country
4.4 Asia Pacific Interferons Market by Country
4.5 Asia Pacific Other Drugs Market by Country
Chapter 5. Asia Pacific Autoimmune Disease Therapeutics Market by Distribution Channel
5.1 Asia Pacific Hospital Pharmacy Market by Country
5.2 Asia Pacific Online Market by Country
5.3 Asia Pacific Retail Pharmacies and Drug Stores Market by Country
Chapter 6. Asia Pacific Autoimmune Disease Therapeutics Market by Country
6.1 China Autoimmune Disease Therapeutics Market
6.1.1 China Autoimmune Disease Therapeutics Market by Indication
6.1.2 China Autoimmune Disease Therapeutics Market by Drug Class
6.1.3 China Autoimmune Disease Therapeutics Market by Distribution Channel
6.2 Japan Autoimmune Disease Therapeutics Market
6.2.1 Japan Autoimmune Disease Therapeutics Market by Indication
6.2.2 Japan Autoimmune Disease Therapeutics Market by Drug Class
6.2.3 Japan Autoimmune Disease Therapeutics Market by Distribution Channel
6.3 India Autoimmune Disease Therapeutics Market
6.3.1 India Autoimmune Disease Therapeutics Market by Indication
6.3.2 India Autoimmune Disease Therapeutics Market by Drug Class
6.3.3 India Autoimmune Disease Therapeutics Market by Distribution Channel
6.4 South Korea Autoimmune Disease Therapeutics Market
6.4.1 South Korea Autoimmune Disease Therapeutics Market by Indication
6.4.2 South Korea Autoimmune Disease Therapeutics Market by Drug Class
6.4.3 South Korea Autoimmune Disease Therapeutics Market by Distribution Channel
6.5 Singapore Autoimmune Disease Therapeutics Market
6.5.1 Singapore Autoimmune Disease Therapeutics Market by Indication
6.5.2 Singapore Autoimmune Disease Therapeutics Market by Drug Class
6.5.3 Singapore Autoimmune Disease Therapeutics Market by Distribution Channel
6.6 Malaysia Autoimmune Disease Therapeutics Market
6.6.1 Malaysia Autoimmune Disease Therapeutics Market by Indication
6.6.2 Malaysia Autoimmune Disease Therapeutics Market by Drug Class
6.6.3 Malaysia Autoimmune Disease Therapeutics Market by Distribution Channel
6.7 Rest of Asia Pacific Autoimmune Disease Therapeutics Market
6.7.1 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Indication
6.7.2 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Drug Class
6.7.3 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Distribution Channel
Chapter 7. Company Profiles
7.1 ABBOTT Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Bio-Rad Laboratories, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.3 Johnson and Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 Research & Development Expenses
7.3.1 Recent strategies and developments:
7.3.1.1 Collaborations, partnerships and agreements:
7.4 GlaxoSmithKline PLC (GSK)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and mergers:
7.4.5.2 Collaborations, partnerships and agreements:
7.4.5.3 Product launches:
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Approval:
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Collaborations, partnerships and agreements:
7.6.5.2 Acquisition and mergers:
7.7 Bayer AG (Bayer Schering Pharma AG)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.8 AbbVie, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.9 Amgen, Inc.
7.9.1 Company overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Product launches:
7.9.5.2 Collaborations, partnerships and agreements:
7.1 Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
7.10.5.2 Collaborations, partnerships and agreements:
Unique Offerings 